While the IP law world is being rocked by new developments in biosimilars, patent-eligible subject matter and IPR’s, it is almost refreshing to see a decision upholding the validity of claims to a “small molecule” drug based on application of the principles of obviousness–particularly the no-no of hindsight reconstruction. Shire LLC v. Amneal Pharmaceuticals, LLC, […]
The post Shire v. Amneal Pharma – Adjusting the Rearview Mirror appeared first on Biotechnology Patent Law Blog | Patents4Life by Warren Woessner.